ConductScience.org, home

Paper39837814

Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells.

Zhu GQ and 20 others. Signal Transduct Target Ther, 2025. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells. Papers, record 39837814. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39837814

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells.
PubMed
Journal
Signal Transduct Target Ther
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
4.14, provisional
iCite
Revised in PubMed
2026-08-29
PubMed

Authors21

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhu GQGui-Qihttps://orcid.org/0000-0001-5089-6923
2Tang ZZheng
3Chu THTian-Hao
4Wang BBiao
5Chen SPShi-Ping
6Tao CYChen-Yang
7Cai JLJia-Liang
8Yang RRui
9Qu WFWei-Feng
10Wang YYi
11Zhao QFQian-Fu
12Huang RRun
13Tian MXMeng-Xin
14Fang YYuan
15Gao JJun
16Wu XLXiao-Ling
17Zhou JJianhttps://orcid.org/0000-0002-2118-1117
18Liu WRWei-Ren
19Dai ZZhihttps://orcid.org/0000-0002-4032-9201
20Shi YHYing-Hong

Source PubMed

See all 21 authorsDownload CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Serine-Arginine Splicing FactorsMajor topic
CD8-Positive T-LymphocytesMajor topic
NeoplasmsMajor topic
ImmunotherapyMajor topic
Animals
Mice
Humans
Cell Line, Tumor
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82073217National Natural Science Foundation of China (National Science Foundation of China)PubMed

Source PubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129414259CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.Annu Rev Med2018https://conductscience.org/library/papers/29414259PubMed
233910046Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance.Cell Metab2021https://conductscience.org/library/papers/33910046PubMed
322245967The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation.Nat Struct Mol Biol2012https://conductscience.org/library/papers/22245967PubMed
431200124The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma.Int J Biochem Cell Biol2019https://conductscience.org/library/papers/31200124PubMed
531186238β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma.Cancer Discov2019https://conductscience.org/library/papers/31186238PubMed
68921970Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.Eur J Immunol1996https://conductscience.org/library/papers/8921970PubMed
726431027SRSF1-Regulated Alternative Splicing in Breast Cancer.Mol Cell2015https://conductscience.org/library/papers/26431027PubMed
833398183Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion.Nat Immunol2021https://conductscience.org/library/papers/33398183PubMed
935537409IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy.Cancer Cell2022https://conductscience.org/library/papers/35537409PubMed
1030778251The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity.Nat Immunol2019https://conductscience.org/library/papers/30778251PubMed
1128367982Okanin, effective constituent of the flower tea Coreopsis tinctoria, attenuates LPS-induced microglial activation through inhibition of the TLR4/NF-κB signaling pathways.Sci Rep2017https://conductscience.org/library/papers/28367982PubMed
1220118245Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.J Biol Chem2010https://conductscience.org/library/papers/20118245PubMed
1324368769Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells.J Biol Chem2014https://conductscience.org/library/papers/24368769PubMed
1433951476A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis.Cell Metab2021https://conductscience.org/library/papers/33951476PubMed
1533664238SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer.Signal Transduct Target Ther2021https://conductscience.org/library/papers/33664238PubMed
1633850328Advances in immunotherapy for hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33850328PubMed
1735537411Boosting anticancer immunotherapy through androgen receptor blockade.Cancer Cell2022https://conductscience.org/library/papers/35537411PubMed
189778245Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.Cell1998https://conductscience.org/library/papers/9778245PubMed
1935584166Nivolumab in Esophageal Squamous-Cell Carcinoma.N Engl J Med2022https://conductscience.org/library/papers/35584166PubMed
2026321679Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.Cell2015https://conductscience.org/library/papers/26321679PubMed

See all 38 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42640343Integrated genome-wide high-throughput screening and functional validation identifies Sm proteins as essential splicing regulators for gastric cancer progression.Funct Integr Genomics2026https://conductscience.org/library/papers/42640343PubMed
42625101RNA splicing in health and disease.Mol Biomed2026https://conductscience.org/library/papers/42625101PubMed
42266677Enhancing targeted strategies for cancer immunotherapy by elucidating mRNA processing mechanisms.Front Immunol2026https://conductscience.org/library/papers/42266677PubMed
42063703Electrospun nanofibers for gastric cancer: local therapeutics, biomimetic models, and diagnostic interfaces.Front Oncol2026https://conductscience.org/library/papers/42063703PubMed
41992956SRSF1 as a promising biomarker and key player in the pathogenesis of Alzheimer's disease.Mol Med Rep2026https://conductscience.org/library/papers/41992956PubMed
41663524Peripheral blood CD14 + monocytes in luminal breast carcinoma subtypes: in preliminary research and overview of candidate biomarker proteins.Sci Rep2026https://conductscience.org/library/papers/41663524PubMed
41596632Immunotherapy in Head and Neck Cancer-Where Are We Now and Where Are We Headed?Int J Mol Sci2026https://conductscience.org/library/papers/41596632PubMed
41335261Immunotherapy in multiple myeloma: advances from immune microenvironment insights to clinical application.Mol Biol Rep2025https://conductscience.org/library/papers/41335261PubMed
40732992Orchestrating Nutrient Homeostasis: RNA-Binding Proteins as Molecular Conductors in Metabolic Disease Pathogenesis.Nutrients2025https://conductscience.org/library/papers/40732992PubMed
40537877Mechanism of LINC00958 in ferroptosis of breast cancer through the SRSF1/GPX4 axis.Hereditas2025https://conductscience.org/library/papers/40537877PubMed
40420185Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40420185PubMed
40315321Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma.Sci Adv2025https://conductscience.org/library/papers/40315321PubMed
40308513Transcatheter arterial chemoembolization for lung malignant tumors.Front Oncol2025https://conductscience.org/library/papers/40308513PubMed
40232354Bispecific antibody targeting CD155 mediates T-cell immunotherapy against human gynecological malignancies.Invest New Drugs2025https://conductscience.org/library/papers/40232354PubMed

Download CSV of cited by

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GEOGSE202642

Source GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39837814

GET https://conductscience.org/api/papers/v1/39837814/authors?page=2